Cargando…
Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547987/ https://www.ncbi.nlm.nih.gov/pubmed/32915409 http://dx.doi.org/10.1007/s12325-020-01482-z |
| _version_ | 1783592532730445824 |
|---|---|
| author | Lampertico, Pietro Mauss, Stefan Persico, Marcello Barclay, Stephen T. Marx, Steven Lohmann, Kristina Bondin, Mark Zhang, ZhenZhen Marra, Fiona Belperio, Pamela S. Wedemeyer, Heiner Flamm, Steven |
| author_facet | Lampertico, Pietro Mauss, Stefan Persico, Marcello Barclay, Stephen T. Marx, Steven Lohmann, Kristina Bondin, Mark Zhang, ZhenZhen Marra, Fiona Belperio, Pamela S. Wedemeyer, Heiner Flamm, Steven |
| author_sort | Lampertico, Pietro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7547987 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75479872020-10-19 Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis Lampertico, Pietro Mauss, Stefan Persico, Marcello Barclay, Stephen T. Marx, Steven Lohmann, Kristina Bondin, Mark Zhang, ZhenZhen Marra, Fiona Belperio, Pamela S. Wedemeyer, Heiner Flamm, Steven Adv Ther Correction Springer Healthcare 2020-09-11 2020 /pmc/articles/PMC7547987/ /pubmed/32915409 http://dx.doi.org/10.1007/s12325-020-01482-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Correction Lampertico, Pietro Mauss, Stefan Persico, Marcello Barclay, Stephen T. Marx, Steven Lohmann, Kristina Bondin, Mark Zhang, ZhenZhen Marra, Fiona Belperio, Pamela S. Wedemeyer, Heiner Flamm, Steven Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis |
| title | Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis |
| title_full | Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis |
| title_fullStr | Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis |
| title_full_unstemmed | Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis |
| title_short | Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis |
| title_sort | correction to: real-world clinical practice use of 8-week glecaprevir/pibrentasvir in treatment-naïve patients with compensated cirrhosis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547987/ https://www.ncbi.nlm.nih.gov/pubmed/32915409 http://dx.doi.org/10.1007/s12325-020-01482-z |
| work_keys_str_mv | AT lamperticopietro correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT maussstefan correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT persicomarcello correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT barclaystephent correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT marxsteven correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT lohmannkristina correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT bondinmark correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT zhangzhenzhen correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT marrafiona correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT belperiopamelas correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT wedemeyerheiner correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis AT flammsteven correctiontorealworldclinicalpracticeuseof8weekglecaprevirpibrentasvirintreatmentnaivepatientswithcompensatedcirrhosis |